CommercialCoverageMedium impact
Driving affordability and choice with HUMIRA and biosimilars
Cigna·Rheumatology, Gastroenterology, Dermatology +1 more·Coverage
Effective date
Jun 1, 2024
We identified it
Jun 19, 2026
Summary
Cigna Healthcare now covers HUMIRA biosimilars on their preferred drug lists and offers eligible customers a HUMIRA biosimilar through Accredo at $0 out-of-pocket cost starting in June, potentially saving patients an average of $3,500 per year.
Action Required
By June 2024: Billing team should verify patient eligibility for $0 copay HUMIRA biosimilar through Accredo by Evernorth for Cigna Healthcare patients. Update patient counseling materials to inform eligible patients about biosimilar options and potential cost savings. Contact Accredo to confirm coverage before dispensing.